ADIS is a collaborative effort to improve early diagnosis of Alzheimer’s disease by immune profiling of cytotoxic lymphocytes and recording of sleep disturbances. The research project runs for three years with a budget of 1.3 million EUR, until June 2025. It connects EU-leading expertise in data science, biotechnology, clinical research as well as public involvement...Read More